Case Study: Bluejay Therapeutics speeds drug discovery collaboration with CDD Vault

Bluejay Therapeutics manages 400 small molecules with CDD Vault

Bluejay Therapeutics, a biopharmaceutical company focused on viral and liver diseases, faced challenges in managing its compound and assay data across chemistry, biology, and external partners using spreadsheets. They needed a more reliable, systematic, and collaborative platform to speed up their drug discovery process and turned to CDD Vault from Collaborative Drug Discovery for a solution.

By implementing CDD Vault, Bluejay Therapeutics established a central data repository that served as a "common truth," enhancing collaboration between teams and with CROs. The solution provided intuitive visualization tools, built-in quality control, and exceptional customer support. This enabled faster iteration cycles between compound synthesis and testing, significantly accelerating their time to discovery. The team at Collaborative Drug Discovery provided a cost-effective platform that was easy to administer and helped protect the company's valuable intellectual property.

Bluejay Therapeutics